Skip to main content

CVE detail

CVE-2025-20145

A vulnerability in the access control list (ACL) processing in the egress direction of Cisco IOS XR Software could allow an unauthenticated, remote attacker to bypass a configured ACL. This vulnerability exists because certain packets are handled incorrectly when they are received on an ingress interface on one line card and destined out of an egress interface on another line card where the egress ACL is configured. An attacker could exploit this vulnerability by attempting to send traffic through an affected device. A successful exploit could allow the attacker to bypass an egress ACL on the affected device. For more information about this vulnerability, see the section of this advisory. Cisco has released software updates that address this vulnerability. There are no workarounds that address this vulnerability.

CVSS 5.8 · MediumBuzz score 21.0

Buzz score

Why this CVE is surfacing

Buzz score total 21.0

This all-time snapshot uses the same composite formula as Trending across a 30-year evidence window, rather than a current rolling window.

Buzz score components · mention 11.0 · diversity 10.0 · KEV 0.0 · OTX 0.0 · PoC 0.0
Mention score
11.0
2 evidence mentions in the snapshot
Diversity score
10.0
2 sources across 2 categories
KEV score
0.0
No KEV entry observed
OTX score
0.0
0 OTX pulses
PoC score
0.0
0 repos · best confidence N/A
Best PoC traction
0
Maximum stars on a matched PoC repo

Why it matters now

Mention timeline

Total mentions
0
within the 30d window
Peak daily
0
highest bucket

Evidence

Source links by recency

Newest mentions first
2 source links · newest first

Exploit code

Public exploit repository references

Public PoC repositories are third-party, potentially unsafe artifacts. Treat their code as untrusted and use it only on authorized systems in an isolated, least-privilege environment. cvebuzz does not execute the code or verify that an exploit works.

0 repository references · best confidence N/A · max 0 stars
No public PoC repositories have been matched yet.

Related records

Similar CVEs

6 related CVEs with shared weakness or product evidence